Rajesh Sachdeva to Time Factors
This is a "connection" page, showing publications Rajesh Sachdeva has written about Time Factors.
Connection Strength
0.421
-
Lee MS, Sachdeva R, Kim MH, Sachdeva R. Long-term outcomes of percutaneous coronary intervention in transplant coronary artery disease in pediatric heart transplant recipients. J Invasive Cardiol. 2012 Jun; 24(6):278-81.
Score: 0.077
-
Aleti S, Uretsky BF, Sachdeva R. Utility of fractional flow reserve to determine treatment after recent large myocardial infarction with severe left ventricular dysfunction. Catheter Cardiovasc Interv. 2012 Nov 01; 80(5):830-4.
Score: 0.075
-
Sachdeva R, Eble BK. Rapid progression of coronary aneurysm to stenosis in a patient with Kawasaki disease. J Invasive Cardiol. 2012 Jan; 24(1):36-7.
Score: 0.075
-
Kumar G, Shin EY, Sachdeva R, Shlofmitz E, Behrens AN, Martinsen BJ, Chambers JW. Orbital Atherectomy for the Treatment of Long (=25-40?mm) Severely Calcified Coronary Lesions: ORBIT II Sub-Analysis. Cardiovasc Revasc Med. 2020 02; 21(2):164-170.
Score: 0.033
-
Desai R, Parekh T, Singh S, Patel U, Fong HK, Zalavadia D, Savani S, Doshi R, Sachdeva R, Kumar G. Alarming Increasing Trends in Hospitalizations and Mortality With Heyde's Syndrome: A Nationwide Inpatient Perspective (2007 to 2014). Am J Cardiol. 2019 04 01; 123(7):1149-1155.
Score: 0.031
-
Adedinsewo D, Xu J, Agasthi P, Oderinde A, Adekeye O, Sachdeva R, Rust G, Onwuanyi A. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2017 May; 10(5):e004573.
Score: 0.027
-
Adedinsewo D, Taka N, Agasthi P, Sachdeva R, Rust G, Onwuanyi A. Prevalence and Factors Associated With Statin Use Among a Nationally Representative Sample of US Adults: National Health and Nutrition Examination Survey, 2011-2012. Clin Cardiol. 2016 Sep; 39(9):491-6.
Score: 0.026
-
Willis N, Sachdeva R, Uretsky BF. Bare-metal stent thrombosis after noncardiac surgery greater than 10 years after stent implantation. Catheter Cardiovasc Interv. 2011 Aug 01; 78(2):234-6.
Score: 0.018
-
Brilakis ES, Lichtenwalter C, Abdel-karim AR, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. JACC Cardiovasc Interv. 2011 Feb; 4(2):176-82.
Score: 0.018
-
Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Holper EM, Haagen D, Saeed B, Iturbe JM, Shunk K, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial. JACC Cardiovasc Interv. 2009 Sep; 2(9):855-60.
Score: 0.016
-
Bansal D, Sachdeva R, Mehta JL. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents. J Am Coll Cardiol. 2008 Mar 04; 51(9):970-1; author reply 971-2.
Score: 0.014
-
Zarich SW, Sachdeva R, Fishman R, Werdmann MJ, Parniawski M, Bernstein L, Dilella M. Effectiveness of a multidisciplinary quality improvement initiative in reducing door-to-balloon times in primary angioplasty. J Interv Cardiol. 2004 Aug; 17(4):191-5.
Score: 0.011